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ABSTRACT  
Background: This study aimed to estimate the magnitude of geographical variation in dementia 
rates and suggest explanations for this variation. Small-area studies are scarce, and none has 
adequately investigated the relative contribution of genetic and environmental factors to the 
distribution of dementia. 
Methods: We present two complementary small-area hierarchical Bayesian disease mapping 
studies using the comprehensive Swedish Twin Registry (n=27,680) and the 1932 Scottish Mental 
Survey cohort (n=37,597). The twin study allowed us to isolate the area in order to examine the 
effect of unshared environmental factors. The Scottish Mental Survey study allowed us to 
examine various epochs in the life course – approximately age 11 years and adulthood. 
Results: We found a 2-to 3- fold geographical variation in dementia odds in Sweden, after twin 
random effects – likely to capture genetic and shared environmental variance – were removed. In 
Scotland we found no variation in dementia odds in childhood but substantial variation, 
following a broadly similar pattern to Sweden, by adulthood. 
Conclusions: There is geographical variation in dementia rates. Most of this variation is likely to 
result from unshared environmental factors that have their effect in adolescence or later. Further 
work is required to confirm these findings and identify any potentially modifiable socio-
environmental risk factors for dementia responsible for this geographical variation in risk. 
However, if these factors do exist and could be optimized in the whole population, our results 
suggest that dementia rates could be halved. 
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Dementia is a worldwide public health priority,1 and substantial increases in the number of 
people with this disease are projected.2 Despite numerous drug trials, there are no disease-
modifying treatments, and therefore there is an urgent need to understand the etiology of 
dementia in order to delay or prevent its onset.3,4 The estimates on which health service planning 
and dementia policy are based assume uniform incidence in all regions, whereas there is some 
evidence – variable in quality and conclusions – for geographical variation in dementia rates.5 
Only two previous studies have attempted to separate genetic and environmental effects, and 
these studies used shared surnames6 or shared ancestors7 rather than more robust 
methodologies; there have been no twin or gender-specific studies on this topic. Overall, small-
area studies are scarce and none have adequately investigated the relative contribution of genetic 
and environmental factors to the distribution of dementia.5 While there is a familial aspect of 
dementia risk,8 the importance of non-genetic factors is clear,9,10 and these may act at different 
points throughout the life course.11 
 
Here we present two complementary disease-mapping studies, using data from Sweden and the 
UK to test several linked research questions. First, does the distribution of cases of dementia 
indeed vary geographically in these countries? Second, in the twin study, is this variation 
completely explained by familial and genetic factors, or are environmental factors also 
important? Third, in the cohort study, do the various risk factors or protective factors have their 
effects at different stages of life? 
 
METHODS 
Twin study data 
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Participants included older adult members of the Swedish Twin Registry, a population-based 
registry of twins. Dementia status was determined by four related studies: the Study of Dementia 
in Swedish Twins (HARMONY)12; the Swedish Adoption/Twin Study of Aging (SATSA)13; 
Origins of Variance in the Old-Old: Octogenarian Twins (OCTO-Twin)14; and Gender and 
Health: A Study of Older Unlike-Sex Twins (Gender).15 HARMONY was a cross-sectional study 
of the entire Swedish Twin Registry, while the other studies used samples from the Swedish 
Twin Registry and are longitudinal in design. The majority of the sample for the present analyses 
came from HARMONY (84%; SATSA, 12%; OCTO-Twin, 3%; Gender, 2%). Twins who 
participated in HARMONY and another study were recorded as being included in the former for 
the purposes of this study.  
 
The methodology of these studies is described in detail in the articles cited above. Briefly, 
HARMONY involved telephone screening of all twins in the Swedish Twin Registry who were 
aged 65 years or older at the time of screening, either same sex and opposite sex, irrespective of 
co-twin vital status (though twins born before 1926, in the first wave of the Swedish Twin 
Registry, were registered only if both twins were alive and responded when the register was 
compiled in 1961). SATSA included (1) same-sex twin pairs from the Swedish Twin Registry 
who reported that they had been reared apart, and at least one of whom was alive in 1987, and 
(2) matched control twin pairs who had been reared together. Participants aged 50 years and 
older were followed longitudinally and underwent periodic cognitive testing to screen for 
dementia. HARMONY and SATSA twins who screened positive for dementia – and their co-
twin, if still living – were invited to a complete clinical workup for dementia, including 
neurological assessment, neuropsychology, and (in HARMONY) neuroimaging. In addition, a 
complete clinical workup was conducted for a sample of normal control twin pairs. OCTO-Twin 
included twins aged 80 years and older who were alive in the period 1991-1993, with procedures 
similar to SATSA. The “Gender” study included unlike-sex twins born in the years 1906-1925; 
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only same-sex twins had been initially entered into the Swedish Twin Registry, due to the 
technicalities of the genetic models used at the time. Again, procedures were similar to SATSA. 
In the OCTO-Twin or Gender studies, if a twin were suspected to have dementia, medical 
records were ordered and there was a consensus conference to review this information. All 
twins, regardless of source study, received questionnaires about health, exposures, and 
psychosocial topics.  Thus, all of the twin cases were clinically diagnosed.  
 
The total sample comprised 27,680 individuals (25% monozygotic). Dementia status is known 
for all participants, and location of residence in 2008 (3-digit zipcode) was obtained from the 
National Population Registry. Zipcode data were missing/erroneous for 3048 people. Age was 
recorded for all persons – age at diagnosis for people with dementia, and age of death/censoring 
for people without dementia. All participants gave informed consent, and ethical approval was 
granted by the Ethics Committee of Karolinska Institutet, the USC Institutional Review Board, 
and the Swedish Data Inspection Board. 
 
Cohort study data 
On 1 June 1932, almost every child aged 11 years at school in Scotland and born in 1921 sat for 
an identical intelligence test, a version of the Moray House Test No. 12 (n=87,498).16 The 
purpose of this Scottish Mental Survey (SMS1932) was to examine the distribution of intelligence 
across the whole population. The first name, surname, date of birth, school attended, county, 
and mental ability score were recorded in a ledger. 
 
In the late 1990s, the ledgers for all but three Scottish counties (Angus, Fife and Wigtown) were 
discovered. Subsamples of SMS1932 participants in Edinburgh (Lothian; n=550) and Aberdeen 
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(n=275) have been followed up in later life.17-19 In contrast, the present study is based on record 
linkage of the entire SMS1932 cohort for whom data were available (n=86,520, including 
persons without mental ability scores; 81,189 had mental ability scores, 93% of participants in 
the original survey).  
 
Apart from 73 participants in the Lothian Birth Cohort 1921 study who had explicitly withdrawn 
consent to data linkage, the Information Services Division of National Health Service [NHS] 
National Services Scotland linked data for all SMS1932 participants, using probabilistic methods, 
with (1) Scottish Morbidity Records that have recorded every admission to general and 
psychiatric hospitals in Scotland since 1981 and (2) death certificate data. Both sources provide 
age and residential location on admission or death. The date of diagnosis was unknown – 
dementia may have been diagnosed at any point up to and including the current admission – and 
so age at death/censoring was used for people with and without dementia in this study. County 
of school attended and residential location on first mid-life admission to hospital (by definition, 
at least age 60 years, due to the start date of the register) were used as locations for the models. 
For persons who were not admitted to hospital, location at death was used. 
 
All diagnoses recorded in the Scottish Morbidity Records or on death certificates were coded 
according to the International Classification of Diseases (ICD), 9th and 10th revisions. 20,21 
Dementia cases were identified by any mention of codes 290.0 to 290.4, 290.8, 290.9, 291.1, 
291.2, 294.1, 294.2, 294.8, 294.9, and 331.0 to 331.9 for ICD-9 and codes F00-F05.1, F09, G30, 
and G31 for ICD-10. In addition, the Greater Glasgow & Clyde Nursing Homes Medical 
Practice (a primary care medical provider that exclusively treats residents of nursing homes) 
provided details of all their patients born in 1921, including dementia status; these data were 
linked with the main dataset.  
8 
 
 
 
Birthplace was retrieved for a random sample of the original SMS1932 dataset (1%; n=854) from 
birth certificates held by the National Register of Scotland. It was not possible to locate 112 
records (13%, either because no birth records with that name and date of birth were found or 
there were too many associated with a very common name to be certain which was this particular 
individual. Of the 742 for whom records were located, 154 did not attend school in the county 
of their birth; 111 attended school in a neighboring county. Thus, only 43/742 (6%) moved 
further than a neighboring county between birth and age 11 years. 
 
Ethical approval was granted by South East Scotland Research Ethics Committee 3, and use of 
the data was approved by NHS Caldicott Guardians, the Community Health Index Advisory 
Group, and following consideration by the Privacy Advisory Committee to NHS National 
Services Scotland and the Registrar General. 
 
Statistical models 
A standard approach in geographical analyses is to use a Bayesian disease mapping model to 
smooth rates to remove random noise.22-25 The odds of dementia in each area is shrunk to a 
degree related to the odds in each of its neighboring areas. Thus, when this process is carried out 
repeatedly for a larger region comprised of multiple areas each with its own neighbors, this 
results in “smoothed” area-level odds ratios centered on the average odds in that region. These 
data can then be displayed as a map of the odds ratios. Because of differential risk of dementia 
between the sexes26 – even though this has not previously been examined from a geographical 
perspective – we analysed men and women separately. We constructed Bernoulli logistic 
regression models with two levels: (1) the individual, including adjustment for individual-level 
covariates; and (2) the area (see eAppendices 1a and 1b for model syntax). In order to examine 
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the area effect, we used the Besag-York-Mollie model,27 which allows separation of area-level 
random effects into spatially structured and unstructured parts without making a strong spatial 
assumption.28,29 In the Swedish analyses we added separate random effects for monozygotic and 
dizygotic twins. We also constructed models using Alzheimer disease as the outcome of interest. 
 
We used R version 2.15.2 and the R2WinBUGS package30 to run Markov chain Monte Carlo 
simulations in WinBUGS.31-33 Model convergence was diagnosed using the Brooks-Gelman-
Rubin statistic,34,35 and models were compared using the deviance information criterion.36 Area 
effects (odds ratios [ORs] with accompanying 95% credible intervals) were computed by 
exponentiating the sum of the spatially structured and unstructured random effects – i.e. with 
individual and twin-level effects removed. We also report the fraction of the area-level variance 
which was spatially structured as opposed to unstructured error (Fracspatial). The overall area-level 
variation is summarized by the 90% quantile ratio (QR90), which compares the 5th and 95th 
centiles. We produced maps using ArcMap 10.  
 
Sensitivity analyses 
In addition to the main analyses, we planned a number of sensitivity and supplementary analyses 
in order to investigate our findings further. First, we wanted to confirm that results from models 
using the Swedish twins were generalizable to the entire population of Sweden and to confirm 
that there was no consequent geographical bias. We obtained demographic data on the Swedish 
population in 2008 from Statistics Sweden. We then compared the Swedish twins over the age of 
65 years, stratified by county of residence (geocoded from the 5-digit zipcode using ArcMap 10) 
and 5-year age band, to the general population, using the Kolmogorov-Smirnov test 
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We additionally examined the environmental contribution to any observed non-random 
distribution of cases by examining individuals within monozygotic twin pairs discordant for 
dementia. These groups of men (n=134) and women (n=200) with and without dementia are 
perfectly matched for age, sex, and genotype because each group contains one member of each 
monozygotic twin pair. We examined the proportion of monozygotic twins with dementia 
according to the quartile of residential risk derived from the whole twin cohort. 
 
From the original SMS1932 dataset, we were able to identify persons whose records had been 
traced by the Information Services Division of NHS National Services Scotland and those whose 
were not traced, allowing us to examine the possibility of a geographical bias resulting from 
differential linkage rates. Thus we compared linkage rates by county of schooling for all 
participants. Additionally, we were able to compare mental ability scores for individuals with 
successful record linkage and those without. 
 
Given the relatively low linkage rates, it was important to estimate under-ascertainment of 
dementia in the SMS1932 study. We attempted to do this in two ways: (1) comparing a 
subsample of primary care records, and (2) identifying cases of dementia through the Prescribing 
Information System, a national database for Scotland holding information on prescriptions 
dispensed in the community, by looking for prescriptions for cholinesterase inhibitors or 
memantine. We calculated the proportion of additional cases of dementia that would be 
identified by using prescriptions for dementia drugs over and above those identified, using the 
record linkage methodology from the main analysis. The Prescribing Information System is 
indexed by a unique identifier that was used on 81%-88% of dementia prescriptions during 
2009-2012. We were not permitted to link the analytic dataset to the Prescribing Information 
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System, but we were able to identify all prescriptions for these drugs 2009-2012 dispensed to 
individuals born in 1921, a broadly comparable population. These data were linked to hospital 
discharge and mortality data, using deterministic methods. We then calculated the proportion of 
cases of dementia identified from any source that were identified only by the Prescribing 
Information System for each Health Board in Scotland. 
 
RESULTS 
The total pooled Swedish twin sample included 10,683 men and 13,949 women (mean age 78.2 
= [SD = 8.2] and 80.2 [8.1] years, respectively). A total of 343 male and 650 female dementia 
cases were identified. Table 1 and Figure 1 show substantial variation in dementia odds in male 
and female Swedish twins, from Bayesian disease mapping models. Alzheimer dementia models 
gave similar results (eFig. 1). The distribution of twins by age and location was similar to the 
Swedish population (Kolmogorov-Smirnov test: men D=0.12,P=0.12; women D=0.10,P=0.36), 
suggesting no excess of elderly twins in any part of Sweden. The sensitivity analysis allocating 
monozygotic twins discordant for dementia into residential dementia risk quartiles showed a 
two- to three-fold risk ratio between the lowest and highest quartiles (for men, relative risk (RR) 
= 2.7 [95% confidence interval = 1.3 to 5.6]; for women, 2.2 [1.3 to 3.8]) representing 
environmental factors, similar to the overall effect size of non-random geographical variation 
observed in the entire sample (Table 2). Furthermore, comparing the monozygotic and dizygotic 
twin random effects – which give some indication of between-pair variation in dementia odds – 
from models showed no differences (for men, mean difference = 0.002 [95% confidence interval 
= -0.063 to 0.060]; for Women, 0.021 [-0.099 to 0.058]), further supporting the conclusion that 
genetic factors are not driving the distribution of dementia observed in this study. 
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In the Scottish study, a total of 19,272 men (44% overall) and 18,325 women (43% overall) were 
traced in 2012. County of schooling was recorded for all participants. Postcode sector of 
residence at first admission to hospital in mid-life or death was missing/erroneous for 7854 
persons, leaving an analytic sample for the adult models of 14,864 men and 14,879 women. Over 
eight decades of follow-up, 13,317 men and 13,423 women were recorded as having died, leaving 
10% of men and women alive. A total of 1307 male and 2298 female dementia cases were 
identified. 
 
The SMS1932 models using county of schooling show very little geographical variation in 
dementia odds in men or women (Table 1, Fig. 2). Conversely, the models using adult location 
show substantial variation in dementia odds in both sexes. Setting aside data from islands, which 
are more difficult to model, the Scottish data mirrored those of Sweden, with risk generally low in 
the south of the country increasing further north (Table 1, Fig. 2). Alzheimer dementia models 
gave similar results (eFig. 1). 
 
We examined a number of alternative explanations for the observed distribution of dementia 
cases. The linkage rate varied across the country (eTable 1 and eFig. 2) but did not mirror 
dementia odds. It is unlikely that this alone could explain the substantial variation observed, i.e. 
maximum-to-minimum county linkage rate ratios were 1.80 for men and 1.56 for women, 
compared with dementia rates that varied 3-fold (Fig. 2). 
 
Lower intelligence is associated with dementia risk,37 perhaps more strongly with vascular than 
Alzheimer dementia,38 as well as being associated with social class and birth weight,39 Bias in 
record linkage related to intelligence or geographical variation in baseline intelligence might 
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explain the observed variation in dementia odds. Whereas baseline intelligence (IQ based on 
total score) was higher in persons who were untraced compared with those identified through 
record linkage (100.2 vs 99.7; mean difference = 0.52 [95% confidence interval [CI] = 0.31-
0.72]), such a small difference is unlikely to be important. There were some differences in the 
mean intelligence of persons who were and were not identified by record linkage within counties 
(eTable 1), but the largest difference was 3.3 IQ points or 0.2 standard deviations. Given the 
known effect size of IQ on dementia risk,37 this is unlikely to have given rise to the substantial 
variation in dementia observed. Similarly, there was insufficient variation in baseline intelligence 
to explain the observed variation in dementia rates (eFig. 3). 
 
We next examined the possibility that our findings could relate to under-ascertainment of 
dementia cases. Compared with all sources of case-identification, death certification alone missed 
233 male cases of dementia (18%) and 375 (16%) in women (eTable 2) – better than the 28% 
non-reporting of dementia previously described in a Scottish study.40 The present methodology 
did not identify all cases of dementia, but consulting primary care records (which would most 
likely be the next source of data consulted) similarly did not identify every case already found by 
record linkage (eTable 3). Comparing the number of cases identified with prescriptions issued 
for dementia drugs shows that the under-ascertaiment of dementia identified in this way varies 
across the country, but that this pattern alone is very unlikely to have resulted in the findings of 
the present study (eFig. 4). Finally, different rates of undiagnosed dementia across the country 
might have influenced our results. However, estimates of these rates (for example, 36% in 
Grampian and 44% in the Borders41) do not vary sufficiently to explain the observed variation. 
Maps showing the posterior probability for each model are shown in eFig. 5. 
 
DISCUSSION 
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Our main findings are substantial non-random geographical variation in dementia rates in two 
countries; the general pattern was of higher rates in the north compared with the south. This 
variation is not completely explained by familial or genetic factors, confirming the importance of 
other environmental factors in dementia, and there was a doubling of risk between the lowest 
and highest risk areas shown both in the 90% quantile ratios of the main models and in the 
subgroup analysis of monozygotic twins. The Scottish data suggest that these environmental 
factors may have the majority of their effect in adolescence or later.  
 
Comparison with previous literature 
We recently published a systematic review and meta-analysis on geographical variation in 
dementia.5 An increased risk of dementia in northern areas has previously been described in 
Finland,42,43 but studies conducted at the most informative scale are scarce. To our knowledge, 
this is the first study to attempt to separate genetic and environmental effects on geographical 
variation in dementia in this way.  
 
Limitations and strengths of the present study 
Both of the present studies have limitations, but the strengths of one complement any limitations 
in the other. Thus, we can be reassured by the fact that both studies give similar results. Less 
than half of the SMS1932 cohort was traced via record linkage – comparable to the 56% 
response rate in the UK Medical Research Council Cognitive Function and Ageing Study CFAS-
II.44 Reasons for this include name changes, emigration or death prior to the beginning of the 
records, and the probabilistic linkage methods used. Furthermore, dementia cases were identified 
from death certification (which identifies approximately 72% of dementia cases40) and hospital 
discharge statistics, both of which are likely to have missed some cases. However, the Million 
15 
 
 
Men Study used a similar case-finding methodology of combining hospital discharge register data 
with outpatient records.45 The vast majority of dementia cases recorded on hospital discharge 
and on death certificates are recorded as generic “dementia” without further information on 
diagnostic subtype. Hence, it was not feasible to investigate different types of dementia 
separately, though we report Alzheimer disease models in eFigure 1. In contrast, the Swedish 
twins study used robust two-phase screening, with thorough clinical assessment of cases. 
Dementia ascertainment approached completeness – at least in the HARMONY data, which 
constituted the vast majority of the sample.12 Thus, we can be confident that our results do not 
relate to under-ascertainment of dementia cases. Indeed, in the Scottish areas with highest 
dementia odds, it is likely – based on prescribing records – that we under-ascertained the number 
of cases of dementia more than in the rest of the country, particularly among men. Furthermore, 
if there were any systematic bias relating to ascertainment, as with linkage, one would expect 
similar patterns in the childhood and adulthood maps. 
 
The Swedish twins study has only the most recent location available, whereas the SMS1932 study 
has location available at two time points, thus offering some insights into life-course effects. 
Indeed, 94% of the sample of SMS1932 participants whose birth records were examined 
attended school in the county of their birth or a neighboring county. The use of adjacency 
matrices recording neighboring areas in the models means that it is likely that, for the majority, 
almost all exposures between birth and age 11 years will have been captured. However, these 
adjacency matrices make the results for islands more difficult to interpret because they have very 
few automatic neighbours.  
 
The Swedish study includes a broad age range, which introduces heterogeneity and is likely to 
mask any cohort effects. On the other hand, SMS1932 is a narrow age cohort, which brings a 
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number of advantages. Participants have a number of exposures in common, including World 
War II and, importantly, health and social service availability with the post-war introduction of 
the UK NHS and welfare reforms “from the cradle to the grave.” Future research looking at 
narrow age cohorts born in different years could help identify whether certain exposures have a 
greater effect at particular ages (called “sensitive” or “critical” periods in life-course 
epidemiology46). Such hypothetical cohorts would be different ages at the introduction of the 
NHS in 1948. Thus, different patterns of risk in different cohorts might shed light on one or 
more sensitive periods relating to that particular exposure. 
 
Finally, the SMS1932 study does not include information on genetic relatedness, but in the 
Swedish twins study this information is completely known. Indeed, this robust approach to 
examining genetic influences is a substantial strength of this study. An approximate comparison 
of genetic risk in the SMS1932 study can be carried out using the prevalence of one or more 
APOE 4 alleles ascertained in subsamples of study members18,19 in areas of Scotland shown in 
the current study to be at high (Aberdeen: 24%47; n=491) and average risk (Lothian: 26%48,49; 
n=462).  
 
Possible mechanisms 
The results from the main twin study and the subgroup analysis of monozygotic twins discordant 
for dementia suggest that the observed geographical variation in dementia is not the result of 
genetic or shared environmental factors, such as diet, which is likely to be similar within a family. 
Thus, one or more unshared socio-environmental risk factors is likely to be responsible for this 
variation. Furthermore, the different effects seen at different stages of life in the UK study 
suggests that these factors have the majority of their effect in adolescence or later. We are unable 
to shed any light on whether this may relate to an accumulation of risk or whether there may be 
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one or more sensitive or critical periods. Given the magnitude of the effect sizes found, the 
results suggest that if these risk factors could be identified and optimized in the whole 
population, dementia rates could be halved. 
 
We have not sought, in this paper, to identify specific environmental factors that could be 
contributing to non-random geographical variation. Our previous systematic review of the 
literature suggested an effect of rurality in early years – or a protective effect of early urban 
living.5 Some other, related candidates might be poverty and cardiovascular disease risk factors. 
However, the clear north-south effect identified, echoing previous results from Finland,42,43 does 
not fit clearly with urban and rural areas and invites speculation regarding an effect of latitude. 
Sunlight exposure – and consequently vitamin D levels – varies with latitude, and this could be 
consistent with an accumulation of risk. Vitamin D levels have also been associated with 
cognition and risk of dementia.50,51 Another possible candidate is selenium, which again has been 
linked with Alzheimer disease,52 and which is present at lower levels in the soil in northern 
Sweden than further south.53  
 
In conclusion, we present two complementary Bayesian disease mapping studies that confirm 
that the geographical distribution of dementia is not uniform. Most of this geographical variation 
in dementia rates is likely to be the result of unshared environmental factors that have their 
effect in adolescence or later. 
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Table 1. Results from Bayesian disease mapping models  
 
 SWEDEN SCOTLAND 
  Childhood location Mid-life location 
MEN    
Total N 10,683 19,272 14,864 
dementia cases 343 1307 1244 
QR90a (95% Credible 
Interval [CrI]) 
1.49 (1.08 to 
3.11) 
1.17 (1.07 to1.37) 2.48 (1.73 to 3.47) 
Fracspatial, % (95% CrI) 66 (4 to 99) 42 (3 to 90) 96 (78 to 100) 
OR per standard deviation 
increase in age (95% CrI) 
NAa 2.10 (1.98 to 2.23) 2.04 (1.90 to 2.18) 
WOMEN    
Total N 13,949 18,325 14,879 
Dementia cases 650 2298 2207 
QR90 (95% CrI) 
2.15 (1.10 to 
6.08) 
1.20 (1.07 to 1.49) 4.07 (3.07 to 5.45) 
Fracspatial, % (95% CrI) 59 (1 to 100) 38 (3 to 92) 75 (40 to 100) 
OR per standard deviation 
increase in age (95% CrI) 
NAa 2.44 (2.31 to 2.58) 2.37 (2.22 to 2.52) 
QR90 indicates 90% quantile ratio comparing the odds of dementia in the areas on the 5th and 95th centiles. 
Fracspatial, the fraction of the variance of the area effect that is spatially structured; NA, not applicable. 
a Since age-adjustment was adjustment for age at diagnosis for people with dementia and age at death for people 
without dementia in the Swedish study, it is not possible to compute meaningful odds ratios for increasing age 
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Table 2. Persons from complete monozygotic Swedish twin pairs discordant for dementia 
allocated to quartiles of dementia odds, according to area of residence and sex. The groups with 
and without dementia will be, by definition, identically matched by age, sex, and genotype 
 
  Dementia odds ratio 
 Dementia Q1 
(low) 
Q2 
 
Q3 
 
Q4 
(high) 
  No. (%) No. (%) No. (%) No. (%) 
Men No 19 (76.0) 16 (66.7) 14 (41.2) 18 (35.3) 
 Yes 6 (24.0) 8 (33.3) 20 (58.8) 33 (64.7) 
Women No 35 (74.5) 19 (61.3) 18 (31.0) 28 (43.8) 
 
Yes 12 (25.5) 12 (38.7) 40 (69.0) 36 (56.3) 
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Figure 1. Odds ratio of dementia in male (A) and female (B) Swedish twins with twin random 
effects and individual-level effects (age) removed. Models using Alzheimer disease as the 
outcome showed similar effects (eFig. 1) 
 
26 
 
 
Figure 2. Odds ratio of dementia in the SMS1932 cohort by childhood location (A, men; B, 
women) and adult location (C, men; D, women) with individual-level effects (age) removed. 
Models uisng Alzheimer disease as the outcome showed similar effects (eFig. 1) 
 
 
